Disease Info Card

Conjunctival Neoplasms

Information about Conjunctival Neoplasms: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Conjunctival Neoplasms

Most recent studies have shown that Conjunctival Neoplasms shares some biological mechanisms with carcinoma, carcinoma-in-situ, conjunctival-diseases, conjunctival-melanoma, conjunctival-squamous-cell-carcinoma, corneal-diseases, eye-neoplasms, eyelid-neoplasms, lymphoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, malignant-squamous-cell-neoplasm, melanocytic-nevus, melanoma, melanosis, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, orbital-neoplasms, papilloma.

Among the many pathways, these few ones have gauged particular interests from scientists studying Conjunctival Neoplasms, and have been seen in publications frequently: B Cell Proliferation, Cell Cycle, Cell Death, Cell Differentiation, Cell Growth, Cell Proliferation, Coagulation, Dna Repair, Enucleation, Immune Response, Keratinization, Localization, Lymphangiogenesis, Oncogenesis, Pathogenesis, Pigmentation, Secretion, Transport, Wound Healing

Quite a number of genes have been found to play important roles in Conjunctival Neoplasms, such as BCL2, CD5, CTLA4, HLA-DQA1, KRT20, MLANA, MS4A1, MYCBP2, NOD2, PAM, PDXP, S100A1, SERPINB3, SLC25A5, TP53, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.